CN102960719A - Preparation method of functional health food - Google Patents
Preparation method of functional health food Download PDFInfo
- Publication number
- CN102960719A CN102960719A CN2012104312766A CN201210431276A CN102960719A CN 102960719 A CN102960719 A CN 102960719A CN 2012104312766 A CN2012104312766 A CN 2012104312766A CN 201210431276 A CN201210431276 A CN 201210431276A CN 102960719 A CN102960719 A CN 102960719A
- Authority
- CN
- China
- Prior art keywords
- group
- germinatus phragmitis
- obtains
- date
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A preparation method of a functional health food. The method employs asparagus, soy isolated protein and soy lecithin as raw materials to prepare the functional health food; and the raw materials can also be added with jujube or the root of kudzu vine to prepare the functional health food. The functional health food provided by the invention has functions of enhancing immunity, resisting fatigue, reducing blood lipid and assisting protection on chemical liver injury.
Description
Technical field
The present invention relates to a kind of functional health-care food preparation method.
Background technology
Asparagus is nutritious comprehensively, contain a large amount of polysaccharide, saponins compound, Flavonoid substances isoreactivity composition, have the various biological functions such as antitumor, anti-inflammatory, anti-ageing, immunological regulation, and the content of vitamin, carbohydrate and mineral matter all is higher than general fruits and vegetables.Asparagus contains 18 seed amino acids, and wherein aspartate content is the highest, and content of glutamic acid takes second place.Aspartic acid and glutamic acid are excitatory amino acid, can strengthen Abwehrkraft des Koepers, and cardiac muscle is had protective effect, thereby give the effect of asparagus antifatigue, raising immunity.
Soybean protein isolate is a kind of natural polymer water soluble protein, its protein content is more than 90%, the amino acid kind has nearly 20 kinds, can be applicable among the numerous food, can significantly improve and improve original nutritive value of food, can substitute animal protein fully, be the good dietary protein origin that reduces the loss of bone calcium, absorbed by human consumption easily to have the reduction serum cholesterol, prevent the effects such as heart and cranial vascular disease, and safe and reliable.
Soybean lecithin processing is easy to get, cost is low, of many uses; nutritive value and medical value are very high; have and strengthen memory, reduce cholesterol, delay senility, protect the effect such as liver; being described as " the 3rd nutrient " arranged side by side with protein, vitamin, also is one of lipid component of needing of human body.Along with the raising of people's living standard, alcohol and high cholesterol become two key factors of fatty liver, cirrhosis.And the antialcoholism action of soybean lecithin and emulsification, the liver cell that can adequately protect can also promote hepatocellular activation and regeneration simultaneously, strengthens liver function, thereby effectively reduces the illness rate of alcoholic cirrhosis, fatty liver diseases.The health food that asparagus and soybean protein isolate, soybean lecithin compatibility make, the health-care efficacy that not only has three kinds of raw materials, and since three's synergy so that health-care efficacy of the present invention is more obvious, again because soybean protein isolate and soybean lecithin all have good emulsibility, so give this health food good mouthfeel.
Existing data document discloses many functional foods, and wherein portioned product contains asparagus, but does not also adopt the functional health-care food of these three kinds of raw material prescription preparations of asparagus, soybean protein isolate and soybean lecithin at present.Disclose a kind of asparagus protein powder such as Chinese patent CN201210087415.8, take protein powder as primary raw material, asparagus has been obtained extract by water extraction, through concentrated, spray-drying, and mix with protein powder, make the asparagus protein powder.The said goods is to mix the product that makes with protein powder after the water extraction liquid of asparagus is dried to powder again, and asparagus of the present invention is added the health food that soybean protein isolate and soybean lecithin are made various ways again through broken juice.And for example to disclose a kind of be the health beverages of raw material by Sculellaria barbata, oldenlandia diffusa, asparagus to Chinese patent CN00129125.4; Chinese patent CN200910256455.9 discloses a kind of by 21 kinds of capsule for tonifying kidneys and nourishing brain that the Chinese medicine material compatibility is made such as asparagus; It is the health food of raw material by more than the 10 kind materials such as glossy ganoderma, asparagus that Chinese patent CN02143026.8 discloses a kind of; Chinese patent CN201010194225.7 discloses a kind of by 10 kinds of health foods that material is primary raw material such as oat, the seed of Job's tears, asparagus.
Summary of the invention
The object of the present invention is to provide a kind of is the preparation functional health-care food method of raw material by asparagus, soybean protein isolate and soybean lecithin, also can add date or the root of kudzu vine in above-mentioned raw materials, prepares polyfunctional health food.
The date nature and flavor are sweet flat, nontoxic, are regarded as nourishing non-defective unit from ancient times.Compendium of Material Medica is said: " date master trusted subordinate perverse trend in the peace, is supported temper, flat stomach Qi, and logical nine orifices helps 12 warps, mends weak breath, and few body fluid is not enough in the body, frightened heaviness of limbs, and hundred medicines, clothes are made light of one's life by commiting suicide and are prolonged life for a long time." date not only contains more protein, vitamins and other nutritious components; also be rich in the functional components such as date polysaccharide, cyclic adenosine monophosphate, organic acid and triterpenes, flavonoids and date compound sugar, have the effects such as anti-ageing, anticancer, antifatigue, protection liver, reducing blood lipid, raising immunity.So the present invention can also add the date of 5 ~ 30 weight portions, reach enhancing health-care efficacy of the present invention.
The root of kudzu vine sweet cold of distinguishing the flavor of is good to eat, and its main component is starch, contains in addition 12% the flavone compound of having an appointment, and comprises that soybean (soya bean) glucoside, daidzein, Puerarin etc. more than 10 plant; And contain Daucosterol, amino acid, Coumarins etc.The root of kudzu vine has therapeutic action to hypertension, high fat of blood, hyperglycaemia and cardiovascular and cerebrovascular disease, and has the effect of relieving the effect of alcohol, strengthening memory, improve immunity.So the present invention can also add the root of kudzu vine of 5 ~ 40 weight portions, reach enhancing health-care efficacy of the present invention.
The objective of the invention is by the following technical programs to realize with processing step:
1, presses column weight amount umber and take by weighing raw material: 15 ~ 450 parts of asparagus, 2 ~ 20 parts of soybean protein isolates, 1 ~ 10 part of soybean lecithin, 5 ~ 30 parts in date, 5 ~ 40 parts of the roots of kudzu vine;
2, asparagus passes through segmentation, cleans, adds water or does not add the water fragmentation, squeezes the juice, filters, obtains Germinatus Phragmitis extract;
3, Germinatus Phragmitis extract, soybean protein isolate and soybean lecithin are mixed, obtain functional health-care food;
4, adding quality in the date is its water of 8 times, for the first time infusion 2h, filtering and collecting filter liquid, add again 6 times to the water of date, for the second time infusion 2h, after the filtration twice filtrate is merged through the concentrated date juice that obtains, and with Germinatus Phragmitis extract and date juice fully mix rear adding soybean protein isolate, soybean lecithin obtains functional health-care food;
5,30% ~ 90% ethanol that adds certain volume after the root of kudzu vine is pulverized, 80 ℃ of heating and refluxing extraction 3 times, each 1h, merging filtrate reclaims solvent, obtains kudzu root extract; Germinatus Phragmitis extract, kudzu root extract, soybean protein isolate, soybean lecithin are mixed, obtain functional health-care food.
Functional health-care food of the present invention verifies through zoopery, have to improve immunity, antifatigue, reducing blood lipid and to the effect of chemical damage auxiliary protection, and the preparation method is simple, is suitable for suitability for industrialized production.
Its function is described in detail as follows:
One, the preparation of sample reagent
Physiological saline group: 0.9%NaCl solution.
The Germinatus Phragmitis extract group: the 300g asparagus passes through segmentation, cleans, adds water or does not add the water fragmentation, squeezes the juice, filters, concentrates, drying obtains Germinatus Phragmitis extract, gets the distilled water of part Germinatus Phragmitis extract adding certain volume and makes the solution that concentration is 5mg/mL.
Test group 1:300g asparagus passes through segmentation, cleans, adds water or does not add the water fragmentation, squeezes the juice, filters, obtains Germinatus Phragmitis extract; Germinatus Phragmitis extract, 5g soybean protein isolate and 3g soybean lecithin are mixed, obtain mixing dry through concentrated, drying, the distilled water that goes the part dry to add certain volume is made the solution that concentration is 10.15mg/mL.
Test group 2:300g asparagus passes through segmentation, cleans, adds water or does not add the water fragmentation, squeezes the juice, filters, obtains Germinatus Phragmitis extract; Adding quality in the 20g date is its water of 8 times, for the first time infusion 2h, and filtering and collecting filter liquid adds 6 times water again, and for the second time infusion 2h after the filtration merges twice filtrate through concentrated and obtains date juice, and Germinatus Phragmitis extract is fully mixed with date juice; 5g soybean protein isolate, 3g soybean lecithin are fully mixed with said mixture, obtain mixing dry through concentrated, drying, get the distilled water of part dry adding certain volume and make the solution that concentration is 13.6mg/mL.
Test group 3:300g asparagus passes through segmentation, cleans, adds water or does not add the water fragmentation, squeezes the juice, filters, obtains Germinatus Phragmitis extract; 60% ethanol that adds certain volume after the 30g root of kudzu vine is pulverized, 80 ℃ of heating and refluxing extraction 3 times, each 1h, merging filtrate reclaims solvent, obtains kudzu root extract; Germinatus Phragmitis extract, kudzu root extract, 5g soybean protein isolate, 3g soybean lecithin are fully mixed, obtain mixing dry through concentrated, drying, get the distilled water of part dry adding certain volume and make the solution that concentration is 14mg/mL.
Two, improve immunity test
1. sample reagent: select physiological saline group, Germinatus Phragmitis extract group, test group 1.
2. animal used as test
Male Balb/C mouse, body weight 18 ~ 22 g are available from medical college of University Of Nanchang Experimental Animal Center.
3. animal grouping and dosage are selected
Get the Balb/C mouse, be divided at random 3 groups by body weight, 15 every group, gavage respectively physiological saline, Germinatus Phragmitis extract and test group 1.Germinatus Phragmitis extract group dosage is that 100 mg/Kg BW, test group 1 dosage are 203mg/Kg BW, and the physiological saline group is all by 0.20mL/10g capacity oral administration.Be administered once every day, continuous 7 days.
4. experiment content
One group of immunization experiment is investigated each sample reagent to the impact of mouse spleen index and thymus index; Two groups of immunization experiments are investigated each sample reagent oral administration to the impact of mouse spleen lymphocyte proliferation; Three groups of immunization experiments carry out mouse carbon and clean up experiment.
5. experimental result
(1) each sample reagent is on the impact of mouse spleen index and thymus index: see Table 1.Analyzed by table 1, compare with the physiological saline group, the spleen index of Germinatus Phragmitis extract group and thymus index have significant difference (P＜0.05), and the spleen index of test group 1 and thymus index have utmost point significant difference (P＜0.01).
Each sample reagent of table 1 on the impact of mouse spleen index and thymus index (
)
| Group | Dosage (mg/Kg BW) | Body weight (g) | Index and spleen index | Thymus index |
| The physiological saline group | / | 23.52±1.99 | 4.14±0.88 | 2.18±0.56 |
| The Germinatus Phragmitis extract group | 100 | 23.63±2.19 | 4.84±0.96 * | 2.86±0.81 * |
| Test group 1 | 203 | 23.87±2.05 | 5.27±0.98 ** | 3.33±0.80 ** |
Annotate: compare * P＜0.05 with the physiological saline group; * P＜0.01.
(2) each sample reagent on the mouse spleen lymphocyte proliferation impact: see Table 2.Analyzed by table 2, compare with the physiological saline group, Germinatus Phragmitis extract group and test group 1 lymphocyte proliferation ability have utmost point significant difference (P＜0.01).
Each sample reagent of table 2 on the mouse spleen lymphocyte proliferation impact (
)
| Group | Dosage (mg/Kg BW) | LSI (SI) |
| The physiological saline group | / | 2.34±0.64 |
| Asparagus ethanol extract group | 100 | 3.40±0.94** |
| Test group 1 | 203 | 3.68±0.99** |
Annotate: compare * P＜0.05 with the physiological saline group; * P＜0.01.
(3) each sample reagent is cleaned up the impact of ability on mouse carbon: see Table 3.Analyzed by table 3, compare with the physiological saline group, the phagocytic index of test group 1 has utmost point significant difference (P＜0.01), and the Germinatus Phragmitis extract group has significant difference (P＜0.05).
Each sample reagent of table 3 on mouse carbon clean up ability impact (
)
| Group | Dosage (mg/Kg BW) | Phagocytic index (α) |
| The physiological saline group | / | 4.34±0.78 |
| The Germinatus Phragmitis extract group | 100 | 5.12±0.93* |
| Test group 1 | 203 | ?5.63±0.95** |
Annotate: compare * P＜0.05 with the physiological saline group; * P＜0.01.
Three, anti-fatigue test
1. sample reagent: select physiological saline group, Germinatus Phragmitis extract group, test group 1, test group 2.
2. animal used as test
Male mice in kunming, body weight 18 ~ 22 g are available from medical college of University Of Nanchang Experimental Animal Center.
3. animal grouping and dosage are selected
Get male mice in kunming, be divided at random 4 groups by body weight, 12 every group, gavage respectively physiological saline, Germinatus Phragmitis extract, test group 1 and test group 2.Germinatus Phragmitis extract group, test group 1, test group 2 dosages are respectively 100 mg/Kg BW, 203 mg/Kg BW, 272 mg/Kg BW, and the physiological saline group is all by 0.20ml/10g capacity oral administration.Be administered once every day, continuous 30 days.Weighed 1 time in per 3 days, and adjust dosage according to body weight.
4. experiment content
[0052] carries out the swimming with a load attached to the body experiment, and measure glutathione peroxidase (GSH-Px) and the MDA (MDA) of mouse whole blood blood lactic acid, liver.
5. experimental result
(1) each sample reagent is to the mice burden swimming time effects: see Table 4.Analyzed by table 4, compare with the physiological saline group, mouse was taken medicine after the week, test group 2 has significant difference (P〉0.05), take medicine after two weeks, the Germinatus Phragmitis extract group power time that exhausts significantly increases (P＜0.05), and test group 1 and test group 2 are utmost point conspicuousness increases (P＜0.01), when mouse was taken medicine to the 3rd week, power exhausts the time and second week does not have marked difference.
Each sample reagent of table 6 to the mice burden swimming time effects (
)
| Group | Dosage (mg/Kg BW) | First all power exhausts the time (S) | Second week power exhausts the time (S) | The 3rd all power exhausts the time (S) |
| Physiological saline | 0 | 302±102 | 297±101 | 316±115 |
| The Germinatus Phragmitis extract group | 100 | 351±125 | 418±161* | 453±192* |
| Test group 1 | 203 | 404±158 | 486±175** | 521±193** |
| Test group 2 | 272 | 476±180* | 554±168** | 559±184** |
Annotate: compare * P＜0.05 with the physiological saline group; * P＜0.01.
(2) each sample reagent is on the impact of mouse biochemical indicator: see Table 5.Analyzed by table 5, compare with the physiological saline group, Germinatus Phragmitis extract group, test group 1 and test group 2 can extremely significantly reduce mouse whole blood blood lactate level (P＜0.01); Germinatus Phragmitis extract group, test group 1 mouse liver GSH-Px content conspicuousness raise (P＜0.05), test group 2 utmost point conspicuousnesses risings (P＜0.01); MDA content has significant difference (P＜0.05) in test group 1 and test group 2 mouse livers.
Each sample reagent of table 5 on the impact of mouse biochemical indicator (
)
Annotate: compare * P＜0.05 with the physiological saline group; * P＜0.01.
Four, reducing blood lipid test
1. sample reagent: select physiological saline group, Germinatus Phragmitis extract group, test group 1.
2. animal used as test
Kunming mouse, body weight 18 ~ 22 g, male and female half and half are available from medical college of University Of Nanchang Experimental Animal Center.
3. animal grouping and dosage are selected
Get Kunming mouse, be divided at random 4 groups by body weight, common control group, hyperlipidemia model group, Germinatus Phragmitis extract group and test group 1,12 every group.Except common control group gave common basal feed, all the other each groups are edible full price mixed fodder all, freely ingests, fetches water, and feeds continuously 30d.Common control group and hyperlipidemia model group gavage physiological saline.The Germinatus Phragmitis extract group gavages Germinatus Phragmitis extract, test group 1 dosage is respectively 100 mg/Kg BW, 203mg/Kg BW, and the physiological saline group is all by 0.20ml/10g capacity oral administration.Be administered once every day, continuous 30 days.
4. experiment content
Measure mice serum T-CHOL (TC), triglycerides (TG), HDL-C (HDL-C), LDL-C (LDL-C).
5. experimental result
(1) each sample reagent is on the impact of Mouse Weight: see Table 6.Analyzed by table 6, respectively organize the Mouse Weight indifference before the test, hyperlipidemia model group body weight and common control group body weight are utmost point significant difference (P＜0.01) after the test, the body weight of Germinatus Phragmitis extract group, test group 1 and common control group significant difference (P＜0.05), Germinatus Phragmitis extract group, test group 1 body weight significantly (P＜0.05) are lower than the hyperlipidemia model group.
Each sample reagent of table 6 on the impact of Mouse Weight (
)
| Group | Body weight/g before the test | Body weight/g after the test | Weightening finish/g | Rate of body weight gain/% |
| Common control group | 18.99±0.96 | 26.81±2.05 | 7.82 | 41.12 |
| The hyperlipidemia model group | 19.00±1.01 | 32.39±3.56** | 13.40 | 70.52 |
| The Germinatus Phragmitis extract group | 19.13±1.21 | 29.15±3.32* △ | 10.03 | 52.41 |
| Test group 1 | 19.16±1.33 | 29.32±3.65* △ | 10.16 | 53.04 |
Annotate: compare * P＜0.05, * * P＜0.01 with common control group; Compare with the hyperlipidemia model group,
△P＜0.05,
△ △P＜0.01.
(2) each sample reagent is on the impact of lipid of mice level: see Table 7.Analyzed by table 7, model group is compared with common group, and the concentration of TG, TC, LDL-C all utmost point conspicuousness raises (P＜0.01), and HDL-C significantly reduces (P＜0.05); With common group of comparison, the TC of Germinatus Phragmitis extract group extremely significantly raises (P＜0.01), and the TC of test group 1 significantly raises (P＜0.05), and TG, the HDL-C of Germinatus Phragmitis extract group and test group 1, LDL-C and common control group there was no significant difference; Compare with the hyperlipidemia model group, the TC of test group 1 extremely significantly reduces (P＜0.01), the HDL-C of Germinatus Phragmitis extract group, test group 1 all is remarkable difference (P＜0.05), LDL-C all is extremely significantly and is lower than (P＜0.01), and the TG of Germinatus Phragmitis extract group has significant difference (P＜0.05), and the TG of test group 1 has utmost point significant difference (P＜0.01).
Each sample reagent of table 7 on the impact of lipid of mice level (
)
| Group | TC(mmol/L) | TG(mmol/L) | HDL-C(mmol/L) | LDL-L(mmol/L) |
| Common control group | 1.14±0.21 | 0.37±0.10 | 0.94±0.19 | 0.28±0.11 |
| The hyperlipidemia model group | 1.55±0.22** | 0.61±0.12** | 0.74±0.13* | 0.60±0.19** |
| The Germinatus Phragmitis extract group | 1.36±0.14** △ | 0.45±0.13 △ | 0.85±0.11 △ | 0.38±0.12 △△ |
| Test group 1 | 1.30±0.17* △△ | 0.42±0.12 △△ | 0.86±0.14 △ | 0.35±0.15 △△ |
Annotate: compare * P＜0.05, * * P＜0.01 with common control group; Compare with the hyperlipidemia model group,
△P＜0.05,
△ △P＜0.01.
Five, chemical damage auxiliary protection test
1. sample reagent: select physiological saline group, Germinatus Phragmitis extract group, test group 1, test group 3.
2. animal used as test
Male mice in kunming, body weight 18 ~ 22 g are available from medical college of University Of Nanchang Experimental Animal Center.
3. animal grouping and dosage are selected
Get Kunming mouse, be divided at random 5 groups by body weight, blank group, damage model group, Germinatus Phragmitis extract group, test group 1 and test group 11,12 every group.Blank group and damage model group gavage physiological saline, other three groups gavage respectively Germinatus Phragmitis extract, test group 1 and test group 3, dosage is respectively 100 mg/Kg BW, 203mg/Kg BW, 281mg/Kg BW, and the physiological saline group is all by 0.20ml/10g capacity oral administration.Be administered once every day, after continuous 30 days, gets 50% ethanol gavage damage model group and three groups of taking medicine, and the gavage amount is 14mL/kg, and the blank group need not gavage ethanol.
4. experiment content
Measure mouse liver glutathione (GSH), MDA (MDA), triglycerides (TG) index.
5. experimental result
The impact of each sample reagent mouse liver GSH, MDA, TG: see Table 8.Analyzed by table 8, model group is compared with common group, and GSH, TG content are utmost point significant difference (P＜0.01), and MDA content is remarkable difference (P＜0.05); With the blank group relatively, (P＜0.05) of Germinatus Phragmitis extract group, TG content significantly raise (P＜0.05); Compare with the damage model group, the GSH content of Germinatus Phragmitis extract group, test group 1 is remarkable difference (P＜0.05), the GSH content of test group 3 is utmost point significant difference (P＜0.01), test group 1,3 MDA content significantly reduce (P＜0.05), Germinatus Phragmitis extract group TG content is remarkable difference (P＜0.05), and test group 1,3 TG content are utmost point significant difference (P＜0.01).
The impact of each sample reagent mouse liver GSH of table 8, MDA, TG (
)
| Group | GSH(mg/L) | MDA(nmol/L) | TG(mmol/L) |
| The blank group | 11.17±1.46 | 25.91±3.32 | 0.58±0.09 |
| The damage model group | 9.37±1.28** | 30.47±4.61* | 0.85±0.17** |
| The Germinatus Phragmitis extract group | 10.42±1.17 △ | 28.37±4.97 | 0.71±0.15* △ |
| Test group 1 | 10.49±1.34 △ | 26.97±3.60 △ | 0.66±0.16 △△ |
| Test group 3 | 10.92±1.38 △△ | 26.57±4.50 △ | 0.64±0.16 △△ |
Annotate: compare * P＜0.05, * * P＜0.01 with the blank group; Compare with the damage model group,
△P＜0.05,
△ △P＜0.01.
The invention has the advantages that the raw material components proportioning is scientific and reasonable, show that through zoopery effect is obvious, have and improve immunity, antifatigue, reducing blood lipid and to the effect of chemical damage auxiliary protection, market prospects are very extensive.
The specific embodiment
Example 1:
Asparagus 450g, soybean protein isolate 2g, soybean lecithin 1g, date 30g;
The preparation method:
(1) asparagus passes through segmentation, cleans, adds water or does not add the water fragmentation, squeezes the juice, filters, obtains Germinatus Phragmitis extract; Adding quality in the date is its water of 8 times, for the first time infusion 2h, and filtering and collecting filter liquid adds 6 times water again, and for the second time infusion 2h after the filtration merges twice filtrate through concentrated and obtains date juice, and Germinatus Phragmitis extract is fully mixed with date juice;
(2) soybean protein isolate, soybean lecithin are mixed with the mixture that step (1) obtains, add water and the liquid beverage auxiliary material commonly used of certain volume, make liquid beverage according to the liquid beverage common process.
Example 2:
Asparagus 150g, soybean protein isolate 200g, soybean lecithin 100g, root of kudzu vine 400g;
The preparation method:
(1) asparagus passes through segmentation, cleans, adds water or does not add the water fragmentation, squeezes the juice, filters, obtains Germinatus Phragmitis extract;
(2) 30% ethanol that adds certain volume after the root of kudzu vine is pulverized, 80 ℃ of heating and refluxing extraction 3 times, each 1h, merging filtrate reclaims solvent, obtains kudzu root extract; Germinatus Phragmitis extract, kudzu root extract, soybean protein isolate, soybean lecithin are mixed, add granule auxiliary material commonly used, according to the agent of granule common process granulation.
Example 3:
Asparagus 300g, soybean protein isolate 5g, soybean lecithin 3g, date 20g;
The preparation method:
(1) asparagus passes through segmentation, cleans, adds water or does not add the water fragmentation, squeezes the juice, filters, obtains Germinatus Phragmitis extract; Adding quality in the date is its water of 8 times, for the first time infusion 2h, and filtering and collecting filter liquid adds 6 times water again, and for the second time infusion 2h after the filtration merges twice filtrate through concentrated and obtains date juice, and Germinatus Phragmitis extract is fully mixed with date juice;
(2) soybean protein isolate, soybean lecithin are mixed with the mixture that step (1) obtains, add pulvis auxiliary material commonly used, make pulvis according to the pulvis common process.
Example 4:
Asparagus 300g, soybean protein isolate 5g, soybean lecithin 3g, root of kudzu vine 30g;
The preparation method:
(1) asparagus passes through segmentation, cleans, adds water or does not add the water fragmentation, squeezes the juice, filters, obtains Germinatus Phragmitis extract;
(2) 60% ethanol that adds certain volume after the root of kudzu vine is pulverized, 80 ℃ of heating and refluxing extraction 3 times, each 1h, merging filtrate reclaims solvent, obtains kudzu root extract; Germinatus Phragmitis extract, kudzu root extract, soybean protein isolate, soybean lecithin are mixed, add tablet auxiliary material commonly used, make tablet according to the tablet common process.
Example 5:
Asparagus 150g, soybean protein isolate 20g, soybean lecithin 10g, date 5g;
The preparation method:
(1) asparagus passes through segmentation, cleans, adds water or does not add the water fragmentation, squeezes the juice, filters, obtains Germinatus Phragmitis extract; Adding quality in the date is its water of 8 times, for the first time infusion 2h, and filtering and collecting filter liquid adds 6 times water again, and for the second time infusion 2h after the filtration merges twice filtrate through concentrated and obtains date juice, and Germinatus Phragmitis extract is fully mixed with date juice;
(2) soybean protein isolate, soybean lecithin are mixed with the mixture that step (1) obtains, add pill auxiliary material commonly used, make pill according to the pill common process.
Example 6:
Asparagus 150g, soybean protein isolate 20g, soybean lecithin 10g, root of kudzu vine 5g;
The preparation method:
(1) asparagus passes through segmentation, cleans, adds water or does not add the water fragmentation, squeezes the juice, filters, obtains Germinatus Phragmitis extract;
(2) 90% ethanol that adds certain volume after the root of kudzu vine is pulverized, 80 ℃ of heating and refluxing extraction 3 times, each 1h, merging filtrate reclaims solvent, obtains kudzu root extract; Germinatus Phragmitis extract, kudzu root extract, soybean protein isolate, soybean lecithin are mixed, add capsule auxiliary material commonly used, make capsule according to the capsule common process.
Example 7:
Asparagus 450g, soybean protein isolate 20g, soybean lecithin 10g, date 5g;
The preparation method:
(1) asparagus passes through segmentation, cleans, adds water or does not add the water fragmentation, squeezes the juice, filters, obtains Germinatus Phragmitis extract; Adding quality in the date is its water of 8 times, for the first time infusion 2h, and filtering and collecting filter liquid adds 6 times water again, and for the second time infusion 2h after the filtration merges twice filtrate through concentrated and obtains date juice, and Germinatus Phragmitis extract is fully mixed with date juice;
(2) soybean protein isolate, soybean lecithin are mixed with the mixture that step (1) obtains, add syrup auxiliary material commonly used, make syrup according to the syrup common process.
Example 8:
Asparagus 300g, soybean protein isolate 5g, soybean lecithin 3g;
The preparation method:
(1) asparagus passes through segmentation, cleans, adds water or does not add the water fragmentation, squeezes the juice, filters, obtains Germinatus Phragmitis extract;
(2) water and the oral liquid that Germinatus Phragmitis extract, soybean protein isolate and soybean lecithin are added certain volume are commonly used auxiliary material, make oral liquid according to the oral liquid common process.
Claims (1)
1. functional health-care food preparation method is characterized in that:
(1) presses column weight amount umber and take by weighing raw material: 15 ~ 450 parts of asparagus, 2 ~ 20 parts of soybean protein isolates, 1 ~ 10 part of soybean lecithin, 5 ~ 30 parts in date, 5 ~ 40 parts of the roots of kudzu vine;
(2) asparagus passes through segmentation, cleans, adds water or does not add the water fragmentation, squeezes the juice, filters, obtains Germinatus Phragmitis extract;
(3) the raw material weight umber by (1) mixes Germinatus Phragmitis extract, soybean protein isolate and soybean lecithin, obtains functional health-care food;
(4) adding quality in the date is its water of 8 times, for the first time infusion 2h, filtering and collecting filter liquid, add again 6 times to the water of date, for the second time infusion 2h, after the filtration twice filtrate is merged through the concentrated date juice that obtains, and by the raw material weight umber of (1) with Germinatus Phragmitis extract and date juice fully mix rear adding soybean protein isolate, soybean lecithin obtains functional health-care food;
(5) 30% ~ 90% ethanol that adds certain volume after the root of kudzu vine is pulverized, 80 ℃ of heating and refluxing extraction 3 times, each 1h, merging filtrate reclaims solvent, obtains kudzu root extract; Raw material weight umber by (1) mixes Germinatus Phragmitis extract, kudzu root extract, soybean protein isolate, soybean lecithin, obtains functional health-care food.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012104312766A CN102960719A (en) | 2012-11-02 | 2012-11-02 | Preparation method of functional health food |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012104312766A CN102960719A (en) | 2012-11-02 | 2012-11-02 | Preparation method of functional health food |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102960719A true CN102960719A (en) | 2013-03-13 |
Family
ID=47791375
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012104312766A Pending CN102960719A (en) | 2012-11-02 | 2012-11-02 | Preparation method of functional health food |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102960719A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103404861A (en) * | 2013-08-19 | 2013-11-27 | 北京绿源求证科技发展有限责任公司 | Food tea electuary capable of nourishing liver and preventing alcoholic liver |
| CN107087795A (en) * | 2017-05-26 | 2017-08-25 | 王忠良 | A kind of anti-fatigue anoxia-tolerance Halth-care composition |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1596738A (en) * | 2004-06-14 | 2005-03-23 | 郭杭建 | Nutrition food |
| CN101309599A (en) * | 2005-11-23 | 2008-11-19 | 可口可乐公司 | High potency sweetener composition with saponin and compositions sweetened therewith |
| CN101437413A (en) * | 2006-05-12 | 2009-05-20 | 可口可乐公司 | Beverage preservatives |
| CN101460068A (en) * | 2006-05-26 | 2009-06-17 | 可口可乐公司 | Beverage compositions comprising a preservative system |
| CN101835392A (en) * | 2007-10-22 | 2010-09-15 | 可口可乐公司 | Beverage and manufacture method thereof based on the juice that neutralizes |
| CN102511710A (en) * | 2011-12-13 | 2012-06-27 | 北京同仁堂健康药业股份有限公司 | Low energy nutrition powder |
| CN102687823A (en) * | 2012-05-24 | 2012-09-26 | 刘侯凤 | Nutrition powder for resisting disease and strengthening body |
-
2012
- 2012-11-02 CN CN2012104312766A patent/CN102960719A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1596738A (en) * | 2004-06-14 | 2005-03-23 | 郭杭建 | Nutrition food |
| CN101309599A (en) * | 2005-11-23 | 2008-11-19 | 可口可乐公司 | High potency sweetener composition with saponin and compositions sweetened therewith |
| CN101437413A (en) * | 2006-05-12 | 2009-05-20 | 可口可乐公司 | Beverage preservatives |
| CN101460068A (en) * | 2006-05-26 | 2009-06-17 | 可口可乐公司 | Beverage compositions comprising a preservative system |
| CN101835392A (en) * | 2007-10-22 | 2010-09-15 | 可口可乐公司 | Beverage and manufacture method thereof based on the juice that neutralizes |
| CN102511710A (en) * | 2011-12-13 | 2012-06-27 | 北京同仁堂健康药业股份有限公司 | Low energy nutrition powder |
| CN102687823A (en) * | 2012-05-24 | 2012-09-26 | 刘侯凤 | Nutrition powder for resisting disease and strengthening body |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103404861A (en) * | 2013-08-19 | 2013-11-27 | 北京绿源求证科技发展有限责任公司 | Food tea electuary capable of nourishing liver and preventing alcoholic liver |
| CN107087795A (en) * | 2017-05-26 | 2017-08-25 | 王忠良 | A kind of anti-fatigue anoxia-tolerance Halth-care composition |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103099089B (en) | Health-care product for reducing blood sugar and blood pressure, relaxing bowels, losing weight, resisting fatigue and improving sexual function and production technology thereof | |
| CN102273680B (en) | Flammulina velutipes polysaccharide composite beverage and preparation method thereof | |
| CN104621287B (en) | A kind of balsam pear peptide tea composition and preparation method thereof | |
| CN109645200A (en) | A kind of maca pressed candy and preparation method thereof | |
| CN103948031B (en) | A kind of deficiency of yang physique health food and preparation method thereof | |
| CN107616490A (en) | A kind of postoperative tailored version clinical nutrition formula of children and preparation method thereof | |
| CN101816425B (en) | Powder mixture of whole American ginseng/giant salamander and preparation method thereof | |
| CN108112973A (en) | A kind of auxiliary lower hyperlipidemia, hypertension, hyperglycemia composition and preparation method thereof | |
| CN109329680A (en) | A kind of composition containing ginseng extract and functional beverage as made from it | |
| CN107455625A (en) | A kind of nutrient for plants beverage and its preparation technology with antifatigue weight losing function | |
| CN112690450A (en) | Composition for relieving alcoholism and protecting liver, preparation method thereof and product containing composition | |
| CN106343567A (en) | Noni oral liquid and preparing method thereof | |
| CN102657304B (en) | Health-care food with double functions of promoting digestion and relieving physical fatigue | |
| CN102274381B (en) | Chinese medicinal composition for reducing blood fat, protecting livers and relieving alcoholism and preparation method thereof | |
| CN102813199A (en) | Health-care food for prevention and adjuvant therapy of cancer, three-high disease and immunity strengthening | |
| CN102090637A (en) | Collagen-containing compound nutritious powder | |
| CN102960719A (en) | Preparation method of functional health food | |
| RU2333677C2 (en) | Dietary supplement | |
| CN103239470B (en) | Dual-mushroom polysaccharide composition containing coprinus comatus polysaccharide and lentinan as well as preparation method and application thereof | |
| CN104208348A (en) | Traditional Chinese medicine preparation with immune regulation function | |
| CN114145374A (en) | Astragalus membranaceus and corn stigma composite tea and preparation method and application thereof | |
| CN103920140A (en) | Compound preparation for reducing blood glucose, body weight and fat for human | |
| CN107439866A (en) | Matrimony vine chickpea plant nutrients beverage and its preparation technology | |
| CN107788515A (en) | A kind of desertliving cistanche nutritive composition and preparation method thereof | |
| CN106173128A (en) | A kind of chocolate with anti-fatigue effect and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130313 |